Barriers and applied activity, quality of life and self‑efficacy in prostate cancer survivors 1 year after completing radiotherapy
Metadatos
Mostrar el registro completo del ítemAutor
Martín-Núñez, Javier; Linares Moya, Marta; Calvache Mateo, Andrés; Lazo Prados, Antonio; Heredia Ciuró, Alejandro; López López, Laura; Valenza, Marie CarmenEditorial
SpringerNature
Materia
Prostate cancer Radiotherapy Physical Activity Self-efficacy Quality of life
Fecha
2023-04-20Referencia bibliográfica
Martín-Núñez, J., Linares-Moya, M., Calvache-Mateo, A. et al. Barriers and applied activity, quality of life and self-efficacy in prostate cancer survivors 1 year after completing radiotherapy. Support Care Cancer 31, 284 (2023). [https://doi.org/10.1007/s00520-023-07729-z]
Patrocinador
Universidad de Granada/ CBUA; The Spanish Ministry of Education (Grant numbers FPU:20/ 01670, FPU:19/02609, FPU:17/00408).Resumen
Purpose The aims of the study were to assess self-reported physical activity (PA) levels, barriers to PA, quality of life and
self-efficacy to manage chronic disease of prostate cancer survivor 1 year after radiotherapy treatment.
Methods A cross-sectional case–control study was performed. Prostate cancer survivor patients treated with radiotherapy
were recruited from the Radiation Oncology Service of the “Complejo Hospitalario Universitario” (Granada) and compared
with age-matched healthy men. Outcomes included were perception of benefits for physical activity and potential barriers
(Exercise Benefits/Barriers Scale), physical activity levels assessed by the International Physical Activity Questionnaire
(IPAQ), quality of life (EuroQol five-dimension three-levels) and self-efficacy (Self-Efficacy to Manage Chronic Disease).
Results A total of 120 patients were included in our study. Significant differences were found between groups with worse
results for the prostate cancer patient group in the variable perception of the benefit of physical activity, potential barriers,
and physical activity. Regarding quality of life and self-efficacy, significant differences were also observed between groups
with a greater score in the control group.
Conclusion In conclusion, the results of this study reveal that self-reported PA levels, as measured using the IPAQ, were
low in prostate cancer survivors after treatment. Results also showed worse perception of benefits for PA and potential barriers
by the cancer survivors. Similarly, the quality of life and self-efficacy to manage chronic disease of prostate cancer
survivors was lower.